Details of the Drug

General Information of Drug (ID: DMFQU7V)

Drug Name

GC-1102

Synonyms

Hepabig; HuS10; HBIG, Korea Green Cross; Hepabig-Gene; Recombinant hepatitis B virus immune globulin, Korea Green Cross; Recombinant anti-HBV monoclonal antibody, Green Cross

Indication

Disease Entry	ICD 11	Status	REF
Hepatitis B virus infection	1E51.0	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0W1QA

References

1	ClinicalTrials.gov (NCT02304315) A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients. U.S. National Institutes of Health.